Valuation Astal Laboratories Limited

Stocks

Delayed Bombay S.E. Other stock markets 07:23:57 24/07/2026 BST			5-day change	1st Jan Change
79.31 ^INR	-1.40%		+0.35%	-8.68%

05-30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-14	Astal Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	36.52	34.77	64.34	118.1	401.9	747.2
Change	-	-4.79%	85.03%	83.54%	240.29%	85.93%
Enterprise Value (EV) ¹	36.38	34.46	64.16	117.2	344.2	862.6
Change	-	-5.27%	86.18%	82.75%	193.57%	150.59%
P/E	-130x	577x	-376x	722x	26.3x	9.45x
PBR	0.71x	0.67x	1.25x	2.27x	1.72x	2.08x
PEG	-	-5x	1x	-4x	0x	0x
Capitalization / Revenue	18.1x	17.2x	30.5x	3.27x	1.7x	1.17x
EV / Revenue	18x	17.1x	30.4x	3.25x	1.45x	1.36x
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0708	0.0152	-0.0431	0.041	1.554	8.043
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.019	2.019	2.108	36.07	236.6	636.6
EBITDA	-	-	-	-	-	-
EBIT	-	-	-	-	-	-
Net income ¹	-0.2815	0.0602	-0.1711	0.164	7.847	89.25
Net Debt ¹	-0.1448	-0.3129	-0.1828	-0.844	-57.64	115.4
Reference price ²	9.19	8.75	16.19	29.60	40.88	76.01
Nbr of stocks (in thousands)	3,974	3,974	3,974	3,990	9,830	9,830
Announcement Date	10/09/20	01/09/21	08/09/22	25/08/23	12/07/24	18/08/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTAL LABORATORIES LIMITED	-	-	-	-	36.29M
ELI LILLY AND COMPANY	35.39x	12.58x	26.43x	0.57%	1,057B
JOHNSON & JOHNSON	27.79x	6.35x	17.58x	2.07%	624B
ABBVIE INC.	33.47x	7.59x	15.59x	2.68%	454B
ROCHE HOLDING AG	20.98x	4.63x	11.4x	2.86%	341B
NOVARTIS AG	21.62x	5.7x	13.97x	2.82%	297B
ASTRAZENECA PLC	21.08x	4.45x	12.3x	1.98%	262B
NOVO NORDISK A/S	14.13x	5.26x	10.83x	3.54%	215B
AMGEN INC.	24.37x	6.41x	11.32x	2.71%	201B
GILEAD SCIENCES, INC.	-47.14x	5.65x	31.2x	2.52%	162B
Average	16.85x	6.51x	16.74x	2.42%	361.4B
Weighted average by Cap.	24.72x	7.88x	18.52x	1.98%